Table 2 Adjuvant chemotherapy
Chemotherapy group (n = 489) | Chemoradiotherapy group (n = 75) | |||
|---|---|---|---|---|
Total course (cycles) | ||||
1–2 | 192 | (39.3) | 21 | (28.0) |
3–4 | 256 | (52.4) | 45 | (60.0) |
≥ 5 | 41 | (8.4) | 9 | (12.0) |
Drug (cycles) | ||||
Cisplatin or carboplatin | ||||
0 | 0 | 0.0 | 2 | (2.7) |
1–2 | 197 | (40.3) | 21 | (28.0) |
3–4 | 258 | (52.8) | 44 | (58.7) |
≥ 5 | 34 | (7.0) | 8 | (10.7) |
Etoposide | ||||
0 | 254 | (51.9) | 18 | (24.0) |
1–2 | 84 | (17.2) | 14 | (18.7) |
3–4 | 132 | (27.0) | 38 | (50.7) |
≥ 5 | 19 | (3.9) | 5 | (6.7) |
Irinotecan | ||||
0 | 416 | (85.1) | 63 | (84.0) |
1–2 | 31 | (6.3) | 7 | (9.3) |
3–4 | 38 | (7.8) | 3 | (4.0) |
≥ 5 | 4 | (0.8) | 2 | (2.7) |